Data from Nicotine Withdrawal Sensitivity, Linkage to chr6q26, and Association of <i>OPRM1</i> SNPs in the SMOking in FAMilies (SMOFAM) Sample

Jill Hardin,Yungang He,Harold S. Javitz,Jennifer Wessel,Ruth E. Krasnow,Elizabeth Tildesley,Hyman Hops,Gary E. Swan,Andrew W. Bergen
DOI: https://doi.org/10.1158/1055-9965.c.6514797
2023-01-01
Abstract:<div>Abstract<p>Background: Nicotine withdrawal symptoms are related to smoking cessation. A Rasch model has been used to develop a unidimensional sensitivity score representing multiple correlated measures of nicotine withdrawal. A previous autosome-wide screen identified a nonparametric linkage (NPL) log-likelihood ratio (LOD) score of 2.7 on chromosome 6q26 for the sum of nine withdrawal symptoms.</p><p>Methods: The objectives of these analyses were to (<i>a</i>) assess the influence of nicotine withdrawal sensitivity on relapse, (<i>b</i>) conduct autosome-wide NPL analysis of nicotine withdrawal sensitivity among 158 pedigrees with 432 individuals with microsatellite genotypes and nicotine withdrawal scores, and (<i>c</i>) explore family-based association of single nucleotide polymorphism (SNP) at the mu opioid receptor candidate gene (<i>OPRM1</i>) with nicotine withdrawal sensitivity in 172 nuclear pedigrees with 419 individuals with both SNP genotypes and nicotine withdrawal scores.</p><p>Results: An increased risk for relapse was associated with nicotine withdrawal sensitivity score (odds ratio, 1.25; 95% confidence interval, 1.10-1.42). A maximal NPL LOD score of 3.15, suggestive of significant linkage, was identified at chr6q26 for nicotine withdrawal sensitivity. Evaluation of 18 <i>OPRM1</i> SNPs via the family-based association test with the nicotine withdrawal sensitivity score identified eight tagging SNPs with global <i>P</i> values <0.05 and false discovery rate <i>Q</i> values <0.06.</p><p>Conclusion: An increased risk of relapse, suggestive linkage at chr6q26, and nominally significant association with multiple <i>OPRM1</i> SNPs were found with Rasch-modeled nicotine withdrawal sensitivity scores in a multiplex smoking pedigree sample. Future studies should attempt to replicate these findings and investigate the relationship between nicotine withdrawal symptoms and variation at <i>OPRM1</i>.(Cancer Epidemiol Biomarkers Prev 2009;18(12):3399–406)</p></div>
What problem does this paper attempt to address?